Earnings summaries and quarterly performance for Teladoc Health.
Executive leadership at Teladoc Health.
Board of directors at Teladoc Health.
Research analysts who have asked questions during Teladoc Health earnings calls.
Jailendra Singh
Truist Securities
7 questions for TDOC
Also covers: ACCD, AGL, AMWL +16 more
Jessica Tassan
Piper Sandler
7 questions for TDOC
Also covers: ACCD, ALHC, AMWL +12 more
Richard Close
Canaccord Genuity Group
6 questions for TDOC
Also covers: ACCD, AHCO, CLOV +15 more
CR
Charles Rhyee
TD Cowen
5 questions for TDOC
Also covers: AMWL, BTSG, CAH +20 more
Daniel Grosslight
Citigroup
5 questions for TDOC
Also covers: ACH, AGL, CAH +13 more
DR
David Roman
Goldman Sachs Group Inc.
5 questions for TDOC
Also covers: ABT, BAX, BBNX +22 more
Sarah James
Cantor Fitzgerald
5 questions for TDOC
Also covers: ACHC, AMED, ARDT +16 more
Sean Dodge
RBC Capital Markets
5 questions for TDOC
Also covers: BTSG, CDMO, CTLT +15 more
Allen Lutz
Bank of America
4 questions for TDOC
Also covers: ACCD, CAH, COR +15 more
LG
Lisa Gill
JPMorgan Chase & Co.
4 questions for TDOC
Also covers: AGL, CAH, CI +15 more
Elizabeth Anderson
Evercore ISI
3 questions for TDOC
Also covers: AGL, ALGN, CAH +24 more
George Hill
Deutsche Bank
3 questions for TDOC
Also covers: AGL, CAH, CI +16 more
Michael Cherny
Leerink Partners
3 questions for TDOC
Also covers: ACCD, ACH, AKBA +23 more
AV
Ayush Vyas
Evercore ISI
2 questions for TDOC
Brian Tanquilut
Jefferies
2 questions for TDOC
Also covers: ACHC, ADUS, AHCO +31 more
GS
Glen Santangelo
Jefferies
2 questions for TDOC
Also covers: ALGN, ANIP, BHC +16 more
JG
Jeff Garro
Stephens
2 questions for TDOC
Also covers: CERT, DH, DOCS +7 more
Ryan MacDonald
Needham & Company
2 questions for TDOC
Also covers: ACCD, AMWL, BNED +21 more
SB
Stan Berenshteyn
Wells Fargo Securities
2 questions for TDOC
Also covers: AMWL, DOCS, GDRX +6 more
SD
Stephanie Davis
Barclays
2 questions for TDOC
Also covers: ACCD, CAH, COR +20 more
SP
Sameer Patel
Evercore Inc.
1 question for TDOC
Also covers: HCAT, PDCO, PRVA
Recent press releases and 8-K filings for TDOC.
Teladoc Health Discusses Strategic Focus, BetterHelp Turnaround, and 2026 Outlook
TDOC
Guidance Update
Debt Issuance
CFO Change
- CEO Chuck Divita outlined his strategic focus on operational rigor, product innovation, and the turnaround of BetterHelp, which previously accounted for about 40% of the company's revenues. The company is also actively searching for a new CFO, with the process progressing well.
- The Integrated Care segment is transitioning from subscription to fee-for-service models, with expected revenue growth and EBITDA margin expansion despite a projected low single-digit decline in membership for the year. Chronic Care enrollment is anticipated to grow, particularly in weight management.
- BetterHelp is pivoting to insurance coverage, with $75 million-$90 million in insurance revenues projected for 2026, expected to ramp notably each quarter and drive stabilization and growth in user numbers.
- Teladoc plans to pay down a material portion of its $1 billion convertible debt due in mid-2026 using existing cash and traditional term debt, after having paid off $550 million of converts due in mid-2025. The company ended the year with $780 million in cash.
5 days ago
Teladoc Health Outlines Strategic Priorities and Financial Outlook for 2026
TDOC
Guidance Update
Revenue Acceleration/Inflection
Debt Issuance
- CEO Charles Divita, nearing two years in his role, has focused on increasing strategic focus, operational rigor, product innovation, and turning around the BetterHelp segment, which previously constituted about 40% of the company's revenues.
- The Integrated Care segment is transitioning from a subscription-based model to fee-for-service, with current membership at approximately 100 million lives. Despite an anticipated low single-digit decline in membership for 2026, revenue growth is still expected due to increased service utilization.
- BetterHelp is pivoting from a direct-to-consumer cash-pay model to insurance coverage, with $75 million to $90 million in insurance revenues guided for 2026, expected to ramp up notably each quarter and drive overall segment growth.
- Teladoc plans to address $1 billion in convertible debt due mid-2026 by paying down a material portion using a combination of traditional term debt and existing cash, aiming for a lower gross leverage position.
- The company anticipates a reasonable ramp in revenue growth and EBITDA margins throughout 2026, driven by visit volumes and chronic care enrollment in Integrated Care, and insurance scaling and international growth in BetterHelp.
5 days ago
Teladoc Health Discusses 2026 Outlook, BetterHelp Turnaround, and Debt Strategy
TDOC
Guidance Update
M&A
Debt Issuance
- BetterHelp's turnaround is focused on scaling insurance coverage, with $75 million-$90 million in insurance revenues guided for 2026, expected to ramp up notably each quarter. This strategy aims to stabilize and grow overall users by converting more of the millions of people who start the registration process but drop off due to cash-pay barriers.
- In the Integrated Care segment, Teladoc is transitioning from a subscription-based model to a fee-for-service (visit-based) model, which is expected to drive revenue growth despite a projected low single-digit decline in its 100 million-life membership base for 2026. Chronic care enrollment is also expected to grow, with increased interest in weight management.
- Teladoc plans to address $1 billion in convertible debt due mid-2026 by paying down a material portion using a combination of existing cash (ended year with $780 million) and traditional term debt, aiming for a lower gross leverage position.
- The company is actively using and investing in AI through its "Teladoc Health Pulse" initiative, leveraging its extensive data and virtual-native operations to enhance engagement and clinical interventions. Its competitive advantages ("moats") include deep embedding in the U.S. healthcare system with 12,000+ clients and 100 million lives, vast data, broad clinical offerings, and expertise in a highly regulated industry.
5 days ago
Teladoc Health Reports Q4 2025 Results and Provides 2026 Guidance
TDOC
Earnings
Guidance Update
New Projects/Investments
- Teladoc Health reported full-year 2025 BetterHelp revenue of $950 million, a 9% decline from the prior year, with an adjusted EBITDA of $42 million.
- For full-year 2026, the company expects consolidated revenue between $2.47 billion and $2.59 billion and adjusted EBITDA between $266 million and $308 million, representing a 2% year-over-year growth at the midpoint for EBITDA.
- The Integrated Care segment is projected to grow revenue by 0.4%-3.9% in 2026, while the BetterHelp segment revenue is guided to decline by 7% to 0.5%. BetterHelp's insurance offering is expected to generate $75 million to $90 million in revenue in 2026, with an annualized run rate of over $100 million by year-end.
- Strategic priorities for 2026 include advancing the U.S. integrated care segment through product innovation and AI-enabled capabilities, and scaling the BetterHelp insurance offering to mitigate direct-to-consumer cash pay headwinds.
Feb 25, 2026, 10:00 PM
Teladoc Health Announces Q4 2025 Results and FY 2026 Outlook
TDOC
Earnings
Guidance Update
Demand Weakening
- Teladoc Health reported Q4 2025 revenue of $642 million and an Adjusted EBITDA of $83.8 million, marking a 12% year-over-year increase. The net loss per share for Q4 2025 was $(0.14).
- The company provided FY 2026 revenue outlook ranging from $2,470 million to $2,587 million and Adjusted EBITDA outlook between $266 million and $308 million.
- For Q1 2026, Teladoc Health expects revenue between $598 million and $620 million and Adjusted EBITDA from $50 million to $62 million.
- As of December 31, 2025, cash and cash equivalents were $781 million, with operating cash flow of $88 million and free cash flow of $53 million for Q4 2025.
Feb 25, 2026, 10:00 PM
Teladoc Health Announces Q4 and Full-Year 2025 Results and Provides 2026 Guidance
TDOC
Earnings
Guidance Update
Demand Weakening
- Teladoc Health reported Q4 2025 consolidated revenue of $642 million and full-year 2025 consolidated revenue of $2.53 billion, a 1.5% decline from the prior year. Full-year adjusted EBITDA was $281 million, with a net loss per share of $1.14.
- For the full year 2025, Integrated Care segment revenue increased 3.3% to $1.58 billion, while BetterHelp segment revenue declined 9% to $950 million. BetterHelp's Q4 adjusted EBITDA significantly improved to $18 million from $4 million in the third quarter.
- The company projects full-year 2026 consolidated revenue to be in the range of $2.47 billion-$2.59 billion and consolidated adjusted EBITDA between $266 million-$308 million. Full-year free cash flow is expected to be $130 million-$170 million.
- BetterHelp's insurance offering is anticipated to generate $75 million-$90 million in revenue in 2026, with an annualized revenue run rate exceeding $100 million by year-end. U.S. integrated care members are expected to end 2026 in the range of 97 million-100 million, a modest decrease from 2025 levels.
Feb 25, 2026, 10:00 PM
Teladoc Health Reports Q4 and Full-Year 2025 Results, Provides 2026 Guidance
TDOC
Earnings
Guidance Update
New Projects/Investments
- Teladoc Health reported Q4 2025 consolidated revenue of $642 million and full-year 2025 consolidated revenue of $2.53 billion, a 1.5% decrease from the prior year. Full-year adjusted EBITDA was $281 million, representing an 11.1% margin.
- The Integrated Care segment grew 4.7% in Q4 2025 to $409 million and 3.3% for the full year to $1.58 billion, while BetterHelp revenue declined 6.7% in Q4 to $233 million and 9% for the full year to $950 million.
- For 2026, Teladoc guides BetterHelp revenue to decline 0.5% to 7% year-over-year, but expects $75 million to $90 million in insurance-based revenue from BetterHelp, with an annualized run rate exceeding $100 million by year-end.
- The company ended 2025 with $781 million in cash after retiring $550 million in convertible debt and plans to address the remaining 2027 convertible notes through a combination of cash and new term loan debt.
Feb 25, 2026, 10:00 PM
Teladoc Health Reports Fourth Quarter and Full Year 2025 Results
TDOC
Earnings
Guidance Update
Demand Weakening
- Teladoc Health reported Fourth Quarter 2025 revenue of $642.3 million, which was flat year-over-year, and Full Year 2025 revenue of $2,530.0 million, down 2% year-over-year. The company posted a net loss of $25.1 million ($0.14 per share) for Q4 2025 and a net loss of $200.3 million ($1.14 per share) for Full Year 2025.
- Adjusted EBITDA for Q4 2025 was $83.8 million, up 12% year-over-year, while Full Year 2025 Adjusted EBITDA was $281.1 million, down 10% year-over-year.
- For Full Year 2025, operating cash flow was $294.4 million (flat year-over-year) and free cash flow was $166.9 million (down 2% year-over-year), with $781.1 million in cash and cash equivalents at year-end.
- The Integrated Care segment revenue increased 5% to $409.1 million in Q4 2025, while the BetterHelp segment revenue decreased 7% to $233.2 million.
- For Full Year 2026, Teladoc Health expects revenue between $2,470 million and $2,587 million, Adjusted EBITDA between $266 million and $308 million, and a net loss per share between ($1.10) and ($0.70).
Feb 25, 2026, 9:04 PM
Teladoc Health Outlines 2026 Strategic Priorities and Product Innovations
TDOC
Product Launch
New Projects/Investments
Demand Weakening
- Teladoc Health is actively transitioning its BetterHelp segment into the insurance-covered benefit space, expanding from 12 states plus DC with plans for a broader national rollout throughout 2026, to address cost as a primary barrier for user conversion and retention.
- The company is launching new products and enhancements for 2026 across its Integrated Care business, including a new 24/7 offering to expand service scope and integrate specialties, new AI-enabled chronic care features, and expanded hybrid care models internationally.
- Teladoc has seen a significant migration from subscription-based to visit-based revenue models, with over 50% of its virtual care revenues in 2025 now coming from visit-based arrangements, which has created some gross margin pressure being offset by cost reductions.
- Teladoc added 8.5 million members in 2025, bringing its total platform membership to 103 million, representing a 10% growth over 2024.
- The company extensively utilizes Artificial Intelligence (AI) across its operations, from BetterHelp's intake process and clinician support to device data analysis in acute care settings, with further proliferation expected in 2026.
Jan 12, 2026, 11:45 PM
Teladoc Health Discusses Q3 2025 Performance and 2026 Strategic Priorities
TDOC
Product Launch
New Projects/Investments
- Teladoc Health reported $2.5 billion in revenues and over $270 million in Adjusted EBITDA on a trailing 12-month basis as of the third quarter of 2025. The company maintained a strong financial position with over $700 million in cash at the end of Q3 2025, after paying off $500 million of converts.
- The company is focused on product innovation for 2026, including the launch of a new 24/7 virtual care offering and new AI-enabled models for chronic care. They are also expanding their BetterHelp insurance model, which covered 12 states plus D.C. by year-end 2025 and is expected to provide access to over 120 million people once scaled, with continued rollout throughout 2026.
- Teladoc noted a shift in its virtual care business, with over 50% of 2025 revenues coming from visit-based arrangements, a change from subscription models that can pressure gross margins but is being mitigated by cost reductions. The company anticipates 2026 to be an "execution year" with both headwinds and tailwinds.
Jan 12, 2026, 11:45 PM
Quarterly earnings call transcripts for Teladoc Health.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more